NFJ Investment Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,884
Closed -$2.89M 324
2022
Q1
$2.89M Sell
5,884
-80,749
-93% -$36.9M 0.06% 257
2021
Q4
$40.2M Sell
86,633
-7,950
-8% -$3.34M 0.73% 30
2021
Q3
$35.3M Sell
94,583
-21,829
-19% -$8.3M 0.69% 34
2021
Q2
$44.4M Sell
116,412
-21,948
-16% -$8.39M 0.84% 19
2021
Q1
$49.7M Buy
+138,360
New +$44.5M 1% 14

Other funds holding ELV

NFJ Investment Group's ELV Position: Q2 2022 in Review

NFJ Investment Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 5,884 shares — an estimated $2.89M sold.

NFJ Investment Group first reported a position in ELV in Q1 2021 and held it in 5 quarters. The position peaked at $49.7M in Q1 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • NFJ Investment Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • NFJ Investment Group sold 5,884 Elevance Health shares in Q2 2022, an estimated $2.89M.
  • NFJ Investment Group first reported a position in Elevance Health in Q1 2021 and held it in 5 quarters.
  • NFJ Investment Group's Elevance Health position peaked at $49.7M in Q1 2021.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on NFJ Investment Group's 13F filing for Q2 2022, filed 12 Aug 2022.